pH-Responsive Nanoparticle Delivery for Senolytic Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nanoparticle systems for age-related disorders lack multi-functional integration to simultaneously restore NAD+ levels, enhance sirtuin activity, clear senescent cells, and enable regenerative therapy, while facing issues of poor bioavailability, rapid clearance, and off-target toxicity.
Innovation Solution
A multi-functional nanoparticle system with a biodegradable core (PLGA or CaP), a pH-responsive liposomal layer, and a magnetic iron oxide outer layer, encapsulating NAD+ precursors, sirtuin activators, and senolytic agents, optionally combined with autologous MSCs for targeted delivery and controlled release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If oral supplementation with NAD+ precursors, sirtuin activators, and senolytic compounds is used, then therapeutic effects are achieved, but bioavailability is poor and rapid clearance occurs
Solution Approach 1:
The patent employs a liposomal shell structure to encapsulate NAD+ precursors, sirtuin activators, and senolytic compounds. This flexible lipid bilayer membrane protects the encapsulated substances from degradation in the gastrointestinal tract and bloodstream, significantly improving bioavailability and preventing rapid clearance while maintaining therapeutic efficacy.
Solution Approach 2:
The patent uses a multi-layer nested structure where the core contains NAD+ precursors and sirtuin activators, which are themselves encapsulated within a liposomal shell containing senolytic compounds. This nested architecture allows sequential release of different therapeutic agents, improving overall bioavailability and sustained therapeutic effect.
2Reliability
If senolytic agents such as dasatinib and quercetin are administered systemically, then senescent cells are cleared, but off-target toxicity increases
Solution Approach 1:
The patent incorporates pH-responsive materials in the liposomal shell that remain stable at physiological pH (7.4) but undergo structural changes in acidic environments (pH 5.0-6.5). This allows senolytic agents to be released selectively at acidic tumor or inflamed tissue sites while maintaining stability in normal circulation, thereby clearing senescent cells with minimal off-target toxicity.
Solution Approach 2:
The patent utilizes pH as a critical parameter to control the release of senolytic agents. The liposomal shell is designed to maintain structural integrity at physiological pH but undergoes destabilization and drug release at acidic pH values characteristic of senescent or diseased microenvironments, achieving selective senescent cell clearance without systemic toxicity.
3Reliability
If nanoparticle delivery systems are used to improve stability and targeting, then delivery efficiency increases, but device complexity increases
Solution Approach 1:
The patent designs a universal liposomal nanoparticle platform that can simultaneously encapsulate and deliver multiple types of therapeutic agents (NAD+ precursors, sirtuin activators, senolytic compounds) with different physicochemical properties. This multi-functional system improves delivery efficiency for various age-related conditions while using a standardized platform that reduces overall development complexity.
Solution Approach 2:
The patent combines lipid-based liposomal materials with pH-responsive polymer components to create a composite nanoparticle system. This composite structure provides both the stability and targeting capabilities needed for efficient delivery, while the modular nature of the composite materials allows for relatively straightforward fabrication and scaling.
4Object-affected harmful factors
If targeted delivery is implemented to reduce systemic side effects, then safety improves, but manufacturing precision requirements increase
Solution Approach 1:
The patent employs passive targeting mechanisms where the liposomal nanoparticles naturally accumulate in senescent or diseased tissues through the enhanced permeability and retention (EPR) effect and pH gradient-driven release. This self-targeting approach improves safety by reducing systemic side effects while avoiding the need for complex active targeting ligands, thereby reducing manufacturing precision requirements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Simultaneously restores NAD+ levels, activates sirtuins, clears senescent cells, and promotes tissue regeneration, with enhanced targeting and regenerative potential, reducing senescent cell burden and increasing NAD+ and sirtuin activity.
Implementation Method 1
an outer layer of magnetic iron oxide nanoparticles configured to facilitate targeted delivery, external magnetic manipulation
Implementation Method 2
configured for pH-responsive release; The system is pH-responsive, providing controlled release of its encapsulated agents under acidic conditions typical of senescent or diseased cellular environments
Implementation Method 3
a biodegradable nanoparticle core, which in certain embodiments is poly(lactic-co-glycolic acid) (PLGA) and in other embodiments is calcium phosphate (CaP)
Data Source
AI summary
Disclosed is a multi-functional nanoparticle delivery system comprising a biodegradable core of poly(lactic-co-glycolic acid) (PLGA) or calcium phosphate (CaP), encapsulating a nicotinamide adenine dinucleotide (NAD+) precursor and a sirtuin activator. Surrounding the core is a liposomal or polymeric layer containing one or more senolytic agents, and an outer layer of magnetic iron oxide nanoparticles for targeted delivery, external manipulation, and imaging. In some embodiments, the nanoparticle surface is functionalized for conjugation with autologous mesenchymal stem cells to enhance homing and regenerative potential. The system is pH-responsive, releasing its payload in acidic microenvironments typical of senescent or diseased cells, while remaining stable at physiological pH. This integrated design supports NAD+ restoration, sirtuin activation, senescent cell clearance, and tissue regeneration. Applications include treatment of age-related diseases, regenerative medicine, cardiovascular and neurodegenerative disorders, and cosmetic skin rejuvenation.